John Marotta Biography and Net Worth

President & Chief Executive Officer of Azenta

Mr. Marotta joined Azenta Life Sciences in September 2024 as President and CEO. He has two decades of experience leading global companies in life sciences, medical devices, and diagnostics.

Prior to joining the company, Mr. Marotta served as Executive in Residence of Patient Square Capital, a leading healthcare investment firm. Previously, he served as CEO and President of PHC Holdings Corporation (formerly Panasonic Health Care), a diversified global life sciences, diagnostics, and medical device company focused on precision healthcare, growing global revenues, and leading its IPO from owners KKR Capital. He also held a variety of senior executive roles in leading life sciences companies, including Danaher, Envista Holdings, and Cardinal Health, where he demonstrated consistent achievement in organic revenue growth, operational efficiencies, and significant value-creating transactions. Mr. Marotta began his career in sales leadership roles for therapeutics and medical device offerings.

Mr. Marotta received his BS from the University of Dayton and his MBA from the University of Denver, Daniels School of Business.

What is John Marotta's net worth?: The estimated net worth of John Marotta is at least $3.70 million as of November 18th, 2024. Mr. Marotta owns 99,612 shares of Azenta stock worth more than $3,700,586 as of March 25th. This net worth estimate does not reflect any other investments that Mr. Marotta may own. Learn More about John Marotta's net worth.
How do I contact John Marotta?: The corporate mailing address for Mr. Marotta and other Azenta executives is 15 Elizabeth Dr, Chelmsford, Massachusetts 01824-4111. Azenta can also be reached via phone at (978) 262-2400 and via email at [email protected]. Learn More on John Marotta's contact information.
Has John Marotta been buying or selling shares of Azenta?: John Marotta has not been actively trading shares of Azenta during the last quarter. Most recently, on Monday, November 18th, John Marotta bought 12,717 shares of Azenta stock. The stock was acquired at an average cost of $39.48 per share, with a total value of $502,067.16. Following the completion of the transaction, the chief executive officer now directly owns 99,612 shares of the company's stock, valued at $3,932,681.76. Learn More on John Marotta's trading history.
Who are Azenta's active insiders?: Azenta's insider roster includes William Cornog (Director), Kimberly Crowley (SVP), Linda De Jesus (Insider), David Gray (SVP, Chief Strategy & New Business Officer), John Marotta (President & Chief Executive Officer), and Olga Pirogova (SVP). Learn More on Azenta's active insiders.
Are insiders buying or selling shares of Azenta?: During the last year, Azenta insiders bought shares 2 times. They purchased a total of 25,217 shares worth more than $997,067.16. During the last year, insiders at the sold shares 4 times. They sold a total of 3,018 shares worth more than $126,689.21. The most recent insider tranaction occured on November, 19th when SVP Olga Pirogova sold 548 shares worth more than $21,958.36. Insiders at Azenta own 10.6% of the company. Learn More about insider trades at Azenta.
Information on this page was last updated on 11/19/2024.

John Marotta Insider Trading History at Azenta

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/18/2024	Buy	12,717	$39.48	$502,067.16	99,612

John Marotta Buying and Selling Activity at Azenta

Azenta Company Overview

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $37.15

$37.10

$38.33

50 Day Range

MA: $46.13

$36.56

$54.75

2 Week Range

Now: $37.15

$35.56

$63.58

Volume

411,751 shs

Average Volume

585,913 shs

Market Capitalization

$1.70 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.52